Synthesis of novel monomers and copolymers from 1-vinylpyrrolidin-2-one:: Attractive materials for drug delivery systems?

被引:17
作者
Engström, JUA [1 ]
Lindgren, LJ [1 ]
Helgee, B [1 ]
机构
[1] Chalmers Univ Technol, Dept Chem & Biol Engn Polymer Technol, SE-41296 Gothenburg, Sweden
关键词
copolymerization; drug delivery systems; functionalization of polymers; polyvinylpyrrolidone;
D O I
10.1002/macp.200500479
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Polyvinylpyrrolidone (PVP) is a synthetic, nontoxic, water-soluble polymer commonly used in a wide range of applications including several pharmaceutical applications. One example of an important application is the controlled release and delivery of therapeutic agents into sites of inflammation or tumours. However, PVP lacks reactive groups, which limits the possibility of adding new functions to the polymer in order to modify its physical and chemical properties. Furthermore, large differences in radical reactivity between 1-vinylpyrrolidin-2-one (NVP) and most other monomers lead to compositional drift during copolymerization. This complicates the introduction of reactive groups into the polymer using this method. Monomers that are derivatives of NVP itself are expected to show smaller differences in radical reactivity and therefore provide a way of preparing PVP with adjustable properties. Here we present the synthesis of five NVP-based monomers and their use in the preparation of functional PVP with adjustable properties in terms of solubility, loading of functional groups, and molar mass. The results show the possibility of tailoring PVP for different biomedical applications e.g. drug delivery systems. [GRAPHICS] Copolymers from 1-vinylpyrrolidin-2-one.
引用
收藏
页码:536 / 544
页数:9
相关论文
共 21 条
[1]  
AZORLOSA JL, 1968, WATER SOLUBLE RESINS, P131
[2]  
Barabas E.S., 1989, ENCY POLYM SCI ENG, V17, P198
[3]  
BARABAS ES, 1969, Patent No. 3468831
[4]  
BARABAS ES, 1969, Patent No. 3467613
[5]   Synthesis of 3,3-di(ethoxycarbonyl)-1-vinylpyrrolidin-2-one and determination of its reactivity ratios with 1-vinylpyrrolidin-2-one [J].
Bencini, M ;
Ranucci, E ;
Ferruti, P ;
Oldani, C ;
Licandro, E ;
Maiorana, S .
MACROMOLECULES, 2005, 38 (20) :8211-8219
[6]   Synthesis and in vitro degradation of poly(N-vinyl-2-pyrrolidone)-based graft copolymers for biomedical applications [J].
Brunius, CF ;
Edlund, U ;
Albertsson, AC .
JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY, 2002, 40 (21) :3652-3661
[7]  
Brunius CF, 2001, MACROMOL RAPID COMM, V22, P1474, DOI 10.1002/1521-3927(20011201)22:18<1474::AID-MARC1474>3.0.CO
[8]  
2-7
[9]  
BUEHLER V, 1984, ACTA PHARM TECHNOL, V30, P317
[10]   Polyvinylpyrrolidone-drug conjugate: Synthesis and release mechanism [J].
D'Souza, AJM ;
Schowen, RL ;
Topp, EM .
JOURNAL OF CONTROLLED RELEASE, 2004, 94 (01) :91-100